Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai

from Scientific Sense ® · host Gill Eapen

Causes of chronic liver diseases, emerging treatments, COVID-19 Dr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.

Episode metadata supplied by the publisher feed · Published Jun 11, 2020

Embed this episode

Attribution link and audio player

Ready to play

Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai

0:00 36:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Scientific Sense ®?

This episode is 36 minutes long.

When was this Scientific Sense ® episode published?

This episode was published on June 11, 2020.

Can I download this Scientific Sense ® episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!